| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.70T | 2.44T | 3.07T | 3.21T | 3.32T | 2.74T |
| Gross Profit | 389.69B | 74.08B | 502.78B | 641.45B | 632.19B | 662.83B |
| EBITDA | 141.09B | 110.18B | 207.68B | 214.65B | 219.97B | 238.73B |
| Net Income | 36.07B | 31.64B | 48.94B | 58.31B | 66.93B | 71.97B |
Balance Sheet | ||||||
| Total Assets | 2.25T | 2.15T | 2.08T | 2.02T | 1.95T | 1.89T |
| Cash, Cash Equivalents and Short-Term Investments | 172.61B | 150.94B | 148.20B | 165.76B | 148.56B | 227.93B |
| Total Debt | 573.00B | 597.72B | 475.69B | 440.23B | 356.70B | 315.52B |
| Total Liabilities | 1.26T | 1.17T | 1.11T | 1.07T | 1.01T | 974.18B |
| Stockholders Equity | 827.51B | 827.82B | 815.82B | 802.99B | 784.71B | 774.18B |
Cash Flow | ||||||
| Free Cash Flow | 11.28B | 33.78B | 10.15B | -10.02B | -37.48B | 80.25B |
| Operating Cash Flow | 151.96B | 163.95B | 149.36B | 161.47B | 116.27B | 225.17B |
| Investing Cash Flow | -133.21B | -148.17B | -161.24B | -155.87B | -95.01B | -145.20B |
| Financing Cash Flow | -25.99B | -25.57B | -19.24B | 22.73B | -39.70B | -57.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.41T | 4.40 | 15.25% | 6.76% | -3.90% | -11.54% | |
77 Outperform | HK$1.07T | 17.31 | 12.12% | 8.97% | -6.04% | -7.87% | |
71 Outperform | HK$2.52T | 8.95 | 10.04% | 6.32% | -1.41% | -2.26% | |
67 Neutral | HK$68.38B | 11.07 | 8.25% | 3.59% | 4.22% | 22.46% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
55 Neutral | HK$710.10B | 6.79 | 4.45% | 5.52% | -7.22% | -15.49% | |
51 Neutral | HK$30.31B | 6.93 | -3.91% | 1.65% | -13.85% | -626.58% |